Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn4resultaten gevonden
Klinische farmacologie

Deprescribing of antihypertensives in the elderly

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Dimokrat Hassan
  • Promoters Patricia van den Bemt Liset van Dijk
  • Co-Promoters Jorie Versmissen Karin Hek
  • Jaar 2019 - 2023

The (positive) effects of antihypertensive drugs in the cardiovascular risk management are undoubted. However, like all drugs, antihypertensive drugs also have negative side-effects. Especially the elderly, are more susceptible for these adverse effects. It's not clear whether the benefits outweight the risks. So is it possible to deprescribe antihypertensive drugs and minimise risks for adverse events, while maintining blood-pressure levels in accordance with guidelines?  

Farmaco-economie

Advances in chemo-efficiency

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Ruben Malmberg
  • Promoters Stefan Sleijfer Prof. Dr. Birgit Koch
  • Co-Promoters Roelof van Leeuwen
  • Jaar 2020 - 2024
  1. The safety of short hydration during cisplatin chemoradiation in head and neck cancer patients: a randmized controlled trial.
  2. The feasibility of 6 monthly gosereline injections in prostate cancer patients. 
  3. Nivolumab administration through an elastomeric pump versus iv bag administration: a patient preference study.
Farmaco-economie

Effectiveness and cost-effectiveness of pharmaceutical pulmonary care in Indonesia

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Deni Iskander
  • Promoters Prof. dr. Maarten Postma
  • Co-Promoters Job van Boven
  • Jaar 2020 - 2024

Farmaceutische zorg bij longziekten in Indonesie.

Farmaco-economie

Economic evaluations of novel hospital dispensed drugs for lung cancer and ILD

  • Universiteit Rijksuniversiteit Groningen
  • Promovendus Lotte Westerink
  • Promoters Prof. dr. Maarten Postma
  • Co-Promoters Job van Boven Cornelis Boersma
  • Jaar 2019 - 2023

Economische evaluaties van dure longmedicatie bij long kanker en ILD/IPF.